Skip to main content
Medications start at $149. No membership fees ever; free shipping to patients’ doors.
✓ Medications start at $149 • ✓ Licensed Providers
Naples-based telehealth · Southwest Florida · Florida · 47 of 50 U.S. states (excluding AK, HI, and AR) · No walk-in address · Call 239-422-6350 · Book Online

What Medications Are GLP-1 for Weight Loss?

What medications are GLP-1? Learn the main GLP-1 drugs for weight loss and diabetes, how they differ, and who may qualify for treatment.

What Medications Are GLP-1 for Weight Loss?

If you have been asking what medications are GLP-1, you are probably not looking for a chemistry lesson. You want to know which drugs fall into this category, what they are used for, and whether one of them might be appropriate for your weight-loss goals.

That is a reasonable question, especially now that GLP-1 medications are being discussed everywhere from primary care offices to social media. The problem is that many people hear brand names without understanding what the drugs actually are, how they differ, or why some are prescribed for diabetes while others are prescribed for chronic weight management.

What medications are GLP-1?

GLP-1 medications are prescription drugs that mimic a hormone called glucagon-like peptide-1. This hormone helps regulate appetite, blood sugar, stomach emptying, and feelings of fullness. In plain terms, these medications can help some patients feel less hungry, reduce food noise, and have better control over eating.

The best-known GLP-1 medications include semaglutide and liraglutide. Tirzepatide is also commonly discussed in the same category, although it works a little differently because it targets both GLP-1 and GIP receptors. From a patient perspective, it is often grouped into the same conversation because it is used in medically guided weight-loss treatment.

The main prescription names people most often hear are Wegovy, Ozempic, Saxenda, Victoza, Zepbound, and Mounjaro. Some are FDA-approved for weight loss, while others are FDA-approved for type 2 diabetes. That distinction matters.

The main GLP-1 medications patients should know

Semaglutide is one of the most recognized GLP-1 medications. It is sold under different brand names depending on the approved use. Wegovy is approved for chronic weight management in eligible patients. Ozempic is approved for type 2 diabetes, though many people know about it because of its effects on appetite and weight.

Liraglutide is another GLP-1 medication. Saxenda is the version approved for weight management, while Victoza is used for type 2 diabetes. Compared with semaglutide, liraglutide is typically taken more often and may not produce the same degree of weight loss for some patients, though individual response varies.

Tirzepatide is not a pure GLP-1 medication, but it belongs in this conversation because patients often compare it directly with semaglutide. It acts on both GLP-1 and GIP pathways. Zepbound is approved for chronic weight management, while Mounjaro is approved for type 2 diabetes. For some patients, tirzepatide may lead to strong weight-loss results, but that does not make it automatically the right fit for everyone.

Other GLP-1 receptor agonists exist as well, including dulaglutide and exenatide. These are better known in diabetes care than in weight-loss discussions. They may still be relevant depending on a patient’s medical history, goals, and insurance situation, but they are not usually the first names people mean when asking about GLP-1 treatment for obesity.

GLP-1 medications for weight loss vs diabetes

This is where confusion usually starts. A medication can belong to the GLP-1 class but have a different FDA-approved indication depending on the brand and dose.

For weight management, the names most people are looking for are Wegovy, Saxenda, and Zepbound. These are specifically approved for chronic weight management in eligible adults, and in some cases certain adolescents, under defined medical criteria.

For type 2 diabetes, common GLP-1 or GLP-1-related medications include Ozempic, Victoza, Mounjaro, Trulicity, and Byetta. Some of these medications may also affect weight, but they were approved primarily for diabetes treatment.

That difference is not just technical. It affects prescribing decisions, insurance coverage, dosing, and how a clinician evaluates whether treatment is medically appropriate.

How these medications work in real life

GLP-1 medications do not work by forcing weight loss through willpower. They help regulate biological signals that influence hunger and eating behavior. For patients who have spent years feeling constantly hungry or preoccupied with food, that shift can be significant.

Many patients describe fewer cravings, smaller portions, and less mental chatter around food. That is one reason these medications have changed the conversation around obesity treatment. They can address part of the biology that traditional dieting often ignores.

Still, results are not identical from one person to the next. Some patients respond well to one medication and struggle with another. Some do better with fewer side effects on semaglutide, while others may be candidates for tirzepatide. Medical history, current conditions, cost, access, and tolerability all matter.

What medications are GLP-1 and which one is best?

There is no single best GLP-1 medication for every patient. The better question is which option is clinically appropriate for your health profile and goals.

If the main goal is chronic weight management, a provider may look at whether you meet eligibility criteria based on body mass index, weight-related conditions, and overall risk factors. They may also consider prior treatment history, how much support you need, and whether you can stay consistent with a structured treatment plan.

If you also have type 2 diabetes, the conversation may be different. Blood sugar control, cardiovascular risk, and medication interactions become a larger part of the decision.

Then there is the real-world side of care. Availability can change. Insurance coverage can be inconsistent. Some medications are more expensive than others. A patient may be medically eligible for one option but need to consider a different path based on access and affordability.

Common side effects and trade-offs

GLP-1 medications can be highly effective, but they are still prescription medications, not casual wellness products. The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and stomach discomfort. These often happen more during dose increases and may improve over time.

Some patients tolerate treatment well. Others find that side effects limit how quickly they can increase the dose or whether they want to continue. That is one reason medically guided care matters. Dosing, follow-up, and symptom management are part of safe treatment.

There are also important safety considerations. Not every patient is a candidate for GLP-1 treatment. Personal history, family history, existing medical conditions, and other medications all need review before prescribing. This is not a one-size-fits-all solution, even if it is a strong option for many people.

Why medical guidance matters with GLP-1 treatment

A lot of people searching what medications are GLP-1 are also trying to sort through conflicting online advice. One source says these drugs are life-changing. Another says they are overhyped. The truth is more practical.

For the right patient, with proper screening and follow-up, GLP-1-based treatment can be a very effective tool. But it works best inside a real medical plan, not as a shortcut and not as a trend. Good care includes eligibility review, prescription oversight, dose adjustments, progress monitoring, and support when questions come up.

That is especially important for adults who have tried diet after diet and have been made to feel like failure was their fault. In many cases, the issue was never a lack of effort. It was that biology, appetite signaling, and long-term weight regulation were not being addressed in a clinically meaningful way.

Who may qualify for a GLP-1 medication?

Eligibility depends on the specific medication and your health background. In general, providers often evaluate body mass index, obesity-related health concerns, previous weight-loss efforts, and whether the benefits outweigh the risks.

This is where a medically guided program can remove a lot of guesswork. Instead of trying to self-diagnose from internet posts, patients can get a real assessment based on current health information and treatment goals. For many busy adults, telehealth has made that process much easier and more private.

At South Florida Trim Clinic, that means patients can explore GLP-1 options if eligible through a structured, physician-guided model designed to keep treatment accessible and straightforward.

If you are trying to figure out what medications are GLP-1, start with the names that matter most: semaglutide, liraglutide, and tirzepatide-related options. Then focus on the question that matters even more - not what is popular, but what is appropriate for your body, your health, and your long-term plan.

Have questions about your own situation?

This article is for general education. Eligibility and treatment decisions are determined by a licensed medical provider.

Request a Free Consultation

Medications start at $149. No membership fees ever; free shipping to patients’ doors.